Literature DB >> 3513642

Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border.

S R Meek, E B Doberstyn, B A Gaüzère, C Thanapanich, E Nordlander, S Phuphaisan.   

Abstract

Three different regimens were compared for treatment of falciparum malaria in displaced Kampucheans living in encampments on the Thai-Kampuchean border in 1983: single dose 750 mg mefloquine, 1.5 g sulfadoxine, 75 mg pyrimethamine (MSP); 600 mg quinine 8-hourly for 3 days and 500 mg tetracycline 8-hourly for 7 days (Q3T7); or 600 mg quinine 8-hourly for 7 days and 500 mg tetracycline 8-hourly for 7 days (Q7T7). Radical cure rates were 98% (40/41) for MSP, 76% (32/42) for Q3T7 and 92% (33/36) for Q7T7. The criterion for treatment failure was reappearance of parasites by 35 days after commencement of treatment or no parasite clearance. Treatment failures comprised one case of reduction but no clearance of parasites (RII resistance) for MSP, 10 recrudescences (RI) for Q3T7 and 3 recrudescences (RI) for Q7T7. The radical cure rate for Q3T7 was significantly lower than that for MSP (P less than 0.01), whilst Q7T7 significantly from the other groups. Parasite clearance time was shorter (2.4 days) with MSP than with Q3T7 (3.5 days) and Q7T7 (3.3 days). There was little difference in side effects between the regimens, and tolerance was good. The MSP and Q7T7 regimens are both effective for treatment, but the single dose of MSP is much easier to manage than 7 days of quinine and tetracycline.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3513642     DOI: 10.4269/ajtmh.1986.35.246

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  24 in total

1.  Development and evaluation of a rapid diagnostic test for Plasmodium falciparum, P. vivax, and mixed-species malaria antigens.

Authors:  Gyu-Cheol Lee; Eun-Sung Jeon; Dung Tien Le; Tong-Soo Kim; Jong-Ha Yoo; Hak Yong Kim; Chom-Kyu Chong
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in Cambodia.

Authors:  Pharath Lim; Sophy Chy; Frédéric Ariey; Sandra Incardona; Pektra Chim; Rithy Sem; Mey Bouth Denis; Sean Hewitt; Stefan Hoyer; Doung Socheat; Odile Merecreau-Puijalon; Thierry Fandeur
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

3.  Mixed falciparum and vivax malaria in Canadian travellers.

Authors:  C Nguyen; J S Keystone; C D Nguyen
Journal:  CMAJ       Date:  1989-07-15       Impact factor: 8.262

Review 4.  Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.

Authors:  N J White
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Malaria on the Thai-Burmese border: treatment of 5192 patients with mefloquine-sulfadoxine-pyrimethamine.

Authors:  F Nosten; S Imvithaya; M Vincenti; G Delmas; G Lebihan; B Hausler; N White
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

Review 6.  Diagnosis and treatment of malaria in Britain.

Authors:  M Molyneux; R Fox
Journal:  BMJ       Date:  1993-05-01

7.  Malaria prophylaxis with proguanil and sulfisoxazole in children living in a malaria endemic area.

Authors:  L W Pang; N Limsomwong; P Singharaj; C J Canfield
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

Review 8.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

9.  Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.

Authors:  J Karbwang; S Looareesuwan; R E Phillips; Y Wattanagoon; M E Molyneux; B Nagachinta; D J Back; D A Warrell
Journal:  Br J Clin Pharmacol       Date:  1987-04       Impact factor: 4.335

10.  Comparison of two mefloquine regimens for treatment of Plasmodium falciparum malaria on the northeastern Thai-Cambodian border.

Authors:  F M Smithuis; J B van Woensel; E Nordlander; W S Vantha; F O ter Kuile
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.